Abstract
The antiangiogenic and neurotrophic growth factor, pigment epithelial derived factor (PEDF), and the proangiogenic growth factor, vascular endothelial growth factor-A (VEGF), are released from retinal pigment epithelial (RPE) cells where they play a critical role in the pathogenesis of age-related macular degeneration (AMD). Since RPE polarity may be altered in advanced AMD, we studied the effect of polarization of differentiated, human RPE monolayer cultures on expression and secretion of PEDF and VEGF. Polarized RPE demonstrated apical microvilli, expression of tight junction proteins, apical localization of Na/K- ATPase, and high transepithelial resistance (490 ± 17 Ω•cm2). PEDF secretion was about 1000 fold greater than that for VEGF in both polarized and non-polarized cultures. Polarization of the RPE monolayer increased PEDF secretion, which was predominantly apical, by 34 fold (p<0.02) and VEGF secretion, which was predominantly basolateral, by 5.7 fold (p<0.02). Treatment of non-polarized RPE cultures with bone morphogenetic protein-4 (BMP-4) had no effect on PEDF or VEGF secretion, but resulted in a dose-dependent >2-fold increase in basolateral VEGF secretion (p<0.05) in polarized cultures. Our data show that polarity is an important determinant of the level of PEDF and VEGF secretion in RPE and support the contention that loss of polarity of RPE in AMD results in marked loss of neurotrophic and vascular support for the retina potentially leading to photoreceptor loss and blindness.
Introduction
The retinal pigment epithelium (RPE),
strategically located between the light sensitive photoreceptors and the choroid, is a monolayer of highly specialized
cells that serves as the outer blood-retinal barrier,
selectively transporting biomolecules between the neural retina and
choriocapillaris, and secreting factors that protect their health and integrity [1,2]. In the last decade, a number
of reports on the utility of in vitro cell culture systems for studyingpathophysiology of RPE have appeared (reviewed in [3]). Cell culture models
can play an important role in gaining knowledge about native tissue since
appropriate RPE function relies on the maintenance of its polarity [3].
Several laboratories have attempted to establish
polarized RPE monolayer cultures using Transwell membrane filters in order to
mimic the native RPE monolayer [3-7]. Most studies have been performed with a
human RPE cell line, ARPE-19, spontaneously transformed using multiple
trypsinizations [8-10]. However, it is common for differentiated cells to lose
their specialized properties after multiple passages; ARPE-19 cells showed
relatively low transepithelial resistance (TER) and depend on highly specific
culture conditions for the development of functional tight junctions [11-13].
In a report comparing the barrier properties of ARPE-19, D-407, primary RPE
cells from C57Bl/6 mouse, and primary human fetal RPE, only those culture
systems with well differentiated monolayers showing high TER (>500 Ω·cm2) were found to be suitable for studying growth factor regulation [14].
Among the methods for polarization of human fetal RPE, the method of Hu and Bok
[4] has been widely recognized for its differentiated phenotype, and high TER;
however, their method requires use of a complex medium including
uncharacterized brain extracts. Recently, a simplified cell culture procedure
was developed using human fetal RPE to produce highly differentiated, polarized
monolayers that were used to demonstrate
asymmetrical polarized secretion of several cytokines [15,16]. Yet, there has been relatively little specific focus on differences
between non-polarized and highly polarized human RPE cells from individual
donors with respect to the level of growth factor expression and secretion.
Disruption of the
equilibrium of secretion from apical and basolateral surfaces of the RPE
monolayer is believed to promote a pathological microenvironment, thus
contributing to various retinal diseases [5,6,17]. For example, in choroidal
neovascularization (CNV), which occurs late during the course of age-related
macular degeneration (AMD) [18,19], dysregulated expression of the
proangiogenic growth factor, vascular endothelial growth factor-A (VEGF)
[20,21], and the neutrotrophic and antiangiogenic growth factor, pigment
epithelium derived growth factor (PEDF) [22], is thought to play an important
role in the pathogenesis of the disease. The primary insult in the late form of
dry AMD (geographic atrophy;GA) appears at the level of RPE and a close relationship
between RPE atrophy and secondary choriocapillaris degeneration was reported [23]. Further in GA, it was recently shown that
progressive RPE alterations occur in the expression of basolaterally located
proteins such as CD63 and MCT3 [24]. Thus, in both late forms of AMD (CNV and
GA) there are alterations in RPE polarity that might contribute to an altered
growth factor microenvironment.
Several cytokines are known to
affect the secretion of VEGF and PEDF [25,26]. In a recent study, it was reported that treatment
of non-polarized ARPE-19 cells with Bone morphogenetic protein-4 (BMP-4)
increased VEGF synthesis and secretion [27]. BMP-4 plays an important role in
RPE development and specification [28,29], is preferentially expressed in RPE
in the adult retina [30,31], and is over-expressed in RPE in dry AMD where it
may play a role in AMD pathogenesis by induction of RPE senescence [32]. The primary aim of this study was
to determine the effect of polarization of RPE on expression and secretion of PEDF
and VEGF in the unstimulated state, and after stimulation with BMP-4.
Results
Functional and
morphological characterization of human polarized RPE cells
As in native tissue, human
RPE cells on Transwell filters formed a monolayer, were well pigmented, and
were arranged in a regular hexagonal array. Confocal immunofluorescent studies
of cultures grown in 1% FBS for one month showed that the intercellular
assemblage outlining each cell was positively stained for tight junction protein
is ZO-1 and occludin (Figure 1A, B). To establish that the cultured RPE cells exhibit
polarity, we stained for the apical marker enzyme Na/K- ATPase. As expected,
Na/K- ATPase was localized to the apical plasma membrane of the RPE cells as
shown in the confocal vertical (X-Z) section (Figure 1C, arrow). Figure1D shows a scanning electron micrograph of the apical
surface of the RPE monolayer with well-developed apicalmicrovilli.
Furthermore, transmission electron micrographs show that RPE have basally
located nuclei, contain melanin pigment granules that congregate on the apical
side of the cytoplasm, and exhibit well-developed tight-junctional complexes
and apical microvilli (Figure 1E).
Weekly measurements of TER
were made in RPE monolayers maintained in 1% FBS for up to one and a half
months. The resistance showed a gradual increase with time and began to plateau
at one month. The TER values in polarized RPE cells at one month averaged
490±17 Ω·cm2 (mean ± SEM, n=48).
Figure 1. Confocal and electron microscopic characterization of polarized RPE cells.
Evidence for tight junction proteins and polarity in fetal RPE cells
cultured on Transwell filters for 6 weeks. (A, B)
Immunofluorescence staining of tight junction proteins ZO-1 and occludin. (C)
Localization of Na/K- ATPase to the apical plasma membrane as shown in the
confocal vertical (X-Z) section (white arrow). (D) Well
differentiated apical microvilli observed by scanning electron microscopy
(SEM). (E) Well developed microvilli (mv), localization of pigment
on the apical side (asterisks), nuclei on basal side (N), and presence of
tight-junctional complexes (arrows) by transmission electron microscopy
(TEM).
Significant difference in PEDF and VEGF secretion
between nonpolarized and polarized RPE
Experiments were performed using
confluent non-polarized, and confluent polarized RPE cells from the same human
donors to determine the influence of polarity on PEDF and VEGF secretion
(Figure 2A). PEDF and VEGF secretion was measured in the supernatants from
both nonpolarized, and polarized RPE cells. The secretion from the
non-polarized cells represents the total growth factor content in the medium of
a 6-well plate, while for polarized cells, the secretion represents the sum of
growth factor content in the apical and basolateral medium; in all cases, data
have been normalized for total cellular protein. The concentration of PEDF was
approximately 1000X greater than that of VEGF-A for both non-polarized and
polarized RPE cultures (Figure 2A). For each donor, the amount of secretion of
PEDF and VEGF in highly polarized RPE cells was significantly higher
(p<0.02) than for confluent, nonpolarized RPE. The amount of VEGF secretion
increased 5.7 fold, while that of PEDF was 33.6 times higher for polarized cells
than non-polarized cells. Similarly, the PEDF and VEGF cellular content,
normalized for total cellular protein, also increased in polarized cells over
non-polarized cells by >100-fold for PEDF (p<0.01) and 15-fold
(p<0.06) for VEGF (Figure 2B). Cellular mRNA expression of both PEDF and
VEGF was also elevated in polarized cells; PEDF mRNA expression was 18 fold
higher in polarized vs non-polarized RPE, while VEGF mRNA expression was
2.8-fold higher in the polarized cells (Figure 2C). These data demonstrate that
induction of polarity in RPE is associated with increased mRNA expression,
increased cellular protein expression, and increased secretion of PEDF and
VEGF.
Polarized secretion of PEDF and VEGF from well
differentiated RPE cells
The extracellular incubation medium from 3 donors was
used to quantify the amount of PEDF and VEGF secreted into the apical vs
basolateral sides. Human polarized RPE cell grown on Transwell culture
membranes secreted PEDF preferentially to the apical side of the tissue
(p<0.03) and VEGF to the basolateral side (p<0.01). The mean (± SEM)
concentration of PEDF in the apical and basolateral supernatants was 14.2 ± 1.5
ng/μg total cellular protein and 6.5 ± 1.1 ng/μg total cellular protein,
respectively (Figure 3A). In contrast, VEGF concentration was 7.5 ± 0.9 pg/μg
total cellular protein (mean ± SEM, apical) and 20.6 ± 0.2 pg/μg total cellular
protein (mean ± SEM, basolateral), in apical and basolateral supernatants
respectively. (Figure 3B). The amount of PEDF secreted into the apical and
basolateral supernatants was >1800 times and >300 times higher than that
of VEGF-A respectively.
Cellular distribution of PEDF by confocal
immunofluorescence staining
Figure 4 shows the confocal
immunofluorescent staining for PEDF in nonpolarized and polarized RPE cells.
The intensity of PEDF staining was found to be much higher for polarized RPE as
compared to nonpolarized RPE. Further, examination of subcellular distribution
in the polarized RPE revealed a progressive increase in PEDF expression from basal to central
to apical regions, with maximal expression seen in the apical region. This pre-dominant
staining in the apical region is consistent with a significantly higher apical
secretion shown in Figure 3.
Figure 2. Differences in PEDF and VEGF secretion between nonpolarized and polarized RPE from various donors after 24h. Secretion from the polarized RPE cells
represent the sum of experimentally determined apical and basolateral
secretion values, normalized for total cellular protein. The total
secretion increased 34 fold for PEDF and 5.7 fold for VEGF-A (A).
Analysis of cellular protein (B) and mRNA (C) showed that
expression in polarized human RPE was higher compared to nonpolarized RPE
cells.
Figure 3. Polarized secretion of PEDF and VEGF in differentiated human RPE cells. Human
polarized RPE cells on transwells isolated from 3 different donors
preferentially secreted PEDF (A) to the apical side of the tissue
and VEGF-A (B) to the basolateral side. The bars represent average
of 2 determinations for each donor with variation in each sample <5%.
Cell cycle analysis of polarized and nonpolarized RPE cells
It has been reported previously that
cellular proliferation/cell cycle can influence
the amount of PEDF secretion by human fibroblast-like cells [33,34]. We
determined whether cells were in cycle vs cellular quiescence by evaluating the
nuclear expression of Ki-67 (cells in cycle) and p27 (cellular quiescence)
under three conditions, viz. confluent RPE (condition 1), confluent-quiescent
non-polarized RPE (condition 2), and confluent polarized RPE (condition 3).
Polarized RPE monolayers showed almost 100% positivity for p27 and barely any
cells (<0.1%) positive for Ki-67 indicating that these cells were in a quiescent stage (Figure 5; Table 1). On the
other hand, the just confluent non-polarized RPE cells showed an opposite
staining pattern with almost 90% of cells positive for Ki-67 and <1% of
cells positive for p27 indicating that these cells were in cell cycle (Table 1). To determine whether the differences in growth factor secretion between
polarized and non-polarized confluent cells were due to differences in cell
cycle, we also evaluated confluent-quiescent cultures (condition 2; cells
cultured an additional 7 days in 1% FBS) for their expression of Ki-67 and
p27, and their levels of growth factor secretion. Confluent-quiescent,
non-polarized cultures were predominantly quiescent with <5% Ki-67
positivity and almost 60% p27 positivity (Table 1); a pattern that was close to
that of polarized RPE monolayers (Table 1). While confluent polarized RPE
showed 33.6 fold increased PEDF secretion compared to confluent non-polarized
RPE, the confluent-quiescent RPE showed only a two fold increase (2.20 ± 0.21,
mean ± SEM) compared to confluent non-polarized RPE cells. These results
provide strong support for the contention that polarization, rather than
quiescence, largely contributes to increased PEDF secretion found in confluent
polarized monolayers.
Table 1. Relative proportion of Ki-67 and p27 positive cells in human RPE cultures.
|
Confluent
|
Confluent
(quiescent)
|
Polarized
|
Ki-67
|
89.87
± 1.72
|
4.45
± 0.52
|
0.09
± 0.09
|
p27
|
0.33
± 0.19
|
56.71
± 6.17
|
99.68
± 0.22
|
Figure 4. Distribution of PEDF in apical, central and basal regions in nonpolarized and polarized RPE cells by confocal microscopy. Staining for PEDF
is more intense in polarized RPE as compared to nonpolarized RPE. The apical
region shows much higher PEDF expression in polarized cells.
Figure 5. Cell cycle analysis of polarized RPE monolayers. (A, B, C)
Expression of p27 (green) and its localization to nuclei (blue). (D, E,
F). Polarized RPE cultures show lack of expression of Ki-67 (green) in
the nuclei. Nuclei counterstained blue with DAPI.
Effect of exogenous BMP-4 treatment on polarized RPE
cells
We then evaluated the effect of polarization of the
RPE monolayer on PEDF and VEGF secretion after stimulation with an exogenous
growth factor. We chose BMP-4 for these studies because BMP-4 plays an
important role in RPE development and specification [28,29], is preferentially
expressed in RPE in the adult retina [30,31], is over-expressed in RPE in dry
AMD [32], and it has been shown to regulated expression of other growth factors
including VEGF [27,35].
To ensure that any changes in growth
factor expression or secretion were not a result of BMP-4 induced cytotoxicity,
we evaluated the effect of 24-hr exposure of BMP-4, in a dose-response manner,
on TER, expression of tight junction proteins, and induction of apoptosis.
Exposure of human polarized RPE (n=4) on Transwell filters to BMP-4 (10-100
ng/ml) did not result in any significant change (ANOVA; p=0.74) in TER versus
untreated controls (Figure 6A). Similarly, immunoblot analysis showed no change
in expression of ZO-1 or occludin in the BMP-4 treated cells vs untreated
controls (Figure 6B). Finally, there was no evidence of apoptosis with
the highest BMP-4 dose (100 ng/ml) treated monolayers as determined by TUNEL
staining (Figure 6C).
Figure 6. Effect of BMP-4 treatment in highly differenti-ated RPE monolayers. (A)
Transepithelial resistance (TER) of polarized human RPE monolayers and
effect of rhBMP-4 treatment. TER values in human RPE monolayers, maintained
for 1 month in 1% FBS-containing medium, averaged 490 ±17 Ω. cm2
(mean ± SEM, n=48). The TER measurements in polarized RPE cells exposed to
rhBMP-4 treatment for 24 h showed no significant difference (P>0.05)
versus untreated controls (n=9/group). (B) Expression levels of
tight junction proteins, ZO-1 and occludin were not significantly different
between the BMP-4 treated and the untreated control groups. (C) No
significant cell death was observed by TUNEL staining in highly polarized
RPE cells of both untreated control and 100ng/ml BMP-4 treatment groups.
Effect of BMP-4 treatment on VEGF and PEDF secretion
in nonpolarized and polarized RPE
The effect of
rhBMP-4 (24 hrs; 10-100 ng/ml) on the secretion of VEGF-A and PEDF from
non-polarized, confluent human RPE cells was determined in RPE isolated from
three individual donors. No significant change in VEGF or PEDF secretion or
cellular protein expression was found in non-polarized RPE after treatment
with BMP-4 at any of the tested doses (Figure 7).
As was shown earlier in Figure 3, VEGF-A is
predominantly secreted from the basolateral domain of polarized RPE monolayers.
After 24 hr treatment with BMP-4, secretion of VEGF from the basolateral side
of the monolayers remained significantly higher (p<0.01) than that from the
apical domain for each BMP-4 concentration ranging from 10 ng/ml to 100 ng/ml
(Figure 8). Moreover, there was a dose-dependent increase in basolateral
secretion of VEGF that was significant at BMP-4 concentrations of 75 and 100
ng/ml, where it was >2-fold greater than secretion from control polarized
monolayers (p<0.05 vs untreated controls, Figure 8B). Importantly, there was
no significant increase in apical secretion of VEGF after treatment with BMP-4
(Figure 8A). While cellular VEGF concentrations tended to increase after BMP-4
treatment, these levels did not achieve statistical significance (Figure 8C).
In contrast to VEGF, neither cellular PEDF expression, nor secretion from
either apical or basolateral domains showed any significant difference after
BMP-4 treatment when compared to untreated polarized controls (Figure 8D, E,
F).
BMP-4 effect on VEGF and
PEDF gene expression in polarized RPE
Figure 9 shows the effect
of rhBMP-4 on expression of VEGF-A and PEDF mRNA in polarized RPE monolayers.
As compared to untreated controls, VEGF-A mRNA expression showed a significant
increase with rhBMP-4 at 50, 75 and 100ng/ml, which was 2.0, 2.3 and 3.4 fold
higher (p<0.05 versus untreated controls, respectively) (Figure 9A). Unlike VEGF-A, levels of PEDF mRNA after rhBMP-4
treatments were not significantly different from those of controls (Figure 9B).
Discussion
We have studied the expression and secretion of the
two key growth factors linked to AMD viz PEDF and VEGF in confluent
human RPE and in highly polarized human RPE monolayers. Our data show that
both PEDF and VEGF are secreted from RPE, with levels of PEDF secretion three
orders of magnitude greater than that for VEGF. Further, in polarized RPE,
PEDF was found to be selectively secreted to the apical side while VEGF
secretion is basolateral. Polarization as compared to quiescence was
predominantly responsible for regulating growth factor secretion in confluent
polarized RPE monolayers. Our studies further showed that BMP-4 induced
selective VEGF secretion to the basolateral side of RPE.
Figure 7. Effect of rhBMP-4 treatment on secretion of VEGF-A and PEDF from nonpolarized RPE cells. Secretion of VEGF-A (A)
and PEDF (C) are presented along with the corresponding cellular
VEGF-A (B) and cellular PEDF (D) from three different donors.
Data are presented as fold difference as compared to untreated controls. The cellular
concentrations of VEGF-A and PEDF did not differ from untreated controls
for the entire BMP-4 concentration range.
Polarization is an essential feature of
the differentiated phenotype of the RPE monolayer allowing for attachment to
Bruch's membrane, formation of the outer blood-retina-barrier, and
specialization of the RPE cells' apical surface for efficient phagocytosis of
shed rod outer segments. Furthermore, the RPE cell plays an essential role in
the vectorial transport of water, electrolytes and nutrients between the
choroid and the neural retina that is also dependent upon the appropriately
polarized expression of the relevant
integral membrane transporters. Another critical, but less studied function of
the RPE layer is the trophic support it provides to the photoreceptors and
choroid through the polarized secretion of trophic growth factors such as PEDF
and VEGF. In the normal eye, apical secretion of PEDF from the RPE into the
interphotoreceptor matrix provides a depot of neurotrophic growth factor
support for the photoreceptors, while basal secretion of VEGF from the RPE
provides constitutive support for the maintenance of the choriocapillaris [36].
Clearly, trophic growth factors must be secreted within a defined concentration
range to be functionally effective.
In disease states such as neovascular AMD and
proliferative vitreoretinopathy, there is considerable evidence that
dysregulated growth factor expression plays a role in disease pathogenesis. For
example, an increase in secretion of VEGF into the pathologic range, with a
decrease in secretion of PEDF out of the trophic range, could promote retinal
neovascularization while decreasing the support of the photoreceptors [37]. In
CNV lesions in AMD, RPE cells become transdifferentiated, lose their polarity
and express very high levels of VEGF, thus promoting the development of CNV
[38]. Recent reports have confirmed that the primary event in GA is at the
level of RPE and that expression and localization of basolateral proteins such
as CD63 and MCT3 diminish with the progression of RPE alteration across GA
lesions, also suggesting loss of polarity in the late dry form of AMD [24]. Ablonczy et al.
[39] suggested that apical PEDF secretion from ARPE-19 cells is important for
protection from oxidant induced secretion of VEGF, a mechanism that may be
operating in vivo to maintain healthy photoreceptors. In this report we
evaluated the hypothesis that polarization of the RPE monolayer is essential
for regulating the appropriate level of expression of trophic growth factors
such as VEGF and PEDF, without increasing VEGF levels to those needed to induce
pathologic angiogenesis.
In this study, the human RPE monolayers in Transwell
filters showed well developed epithelial polarity. The monolayer was
characterized by the following features: the formation of regular polygonal
arrays of cells which increase their pigmentation after cell division, and the
presence of tight junction proteins, ZO-1 and occludin. TEM also showed
tight-junction complexes, cells with cuboidal to columnar shape and polarized
distribution of many organelles. In
addition, SEM revealed high density microvilli akin to resting RPE in vivo. The
above criteria suggest that our Transwell cell culture model displays classic
epithelial polarity. Furthermore, in our study, TER values of polarized RPE
cells averaged as high as 500Ω·cm2. Other polarized cell
culture systems using ARPE-19 cells were found to display morphological
features described above, though in most reports TER values less than
100Ω·cm2 were found [5,11,40]. Higher TER implied that the
cells have well developed tight junctions [41,42], therefore the RPE cells
demonstrated prominent polarity. Taken together, our results suggest that the
cultured RPE cell preparations behaved similarly to that of differentiated
resting RPE in vivo.
Figure 8. Effect of BMP-4 on VEGF-A and PEDF secretion from polarized RPE. Fold change over
control values calculated from ELISA analysis is presented to account for
inter donor variations. (A) The increase in VEGF-A secretion after
treatment with BMP-4 from the apical domain was not statistically
significant (p>0.05). (B) An increase in VEGF-A secretion from
the basolateral domain was found even with the lowest dose used (10ng/ml)
which increased further in a dose-dependent fashion. Asterisk indicates
that VEGF-A secretion with 75 and 100ng/ml BMP-4 treatment was
significantly higher than that of control (p<0.05). (C) The
cellular levels of VEGF-A were not significantly affected by BMP-4
treatment. (D, E, F) No significant change was observed for PEDF
secretion either at the apical domain or the basolateral domain and in
cellular PEDF levels. Data are mean±SEM from four different donors.
Figure 9. Effect of BMP-4 treatment on gene expression of VEGF-A and PEDF in polarized RPE. Expression
of VEGF-A (A) and PEDF (B) mRNA in polarized fetal RPE cells
vs controls was analyzed by real-time PCR. BMP-4 treatment caused an
increase in VEGF-A gene expression, especially at 50, 75, and 100ng/ml
BMP-4 treatment which was significantly different from controls
(p<0.05). PEDF mRNA did not change with BMP-4 dose for the BMP-4 dose
range studied.
Several studies on development of well
defined polarized culture cell systems exist [4,15,16], but to our knowledge,
there is no report on comparison of differences in functional behavior between
polarized and nonpolarized human RPE isolated form the same donors. In this
study, we at first attempted to evaluate the ability and mode of secretion of
PEDF and VEGF-A in both types of RPE cells. It is noteworthy that among the
human RPE cells derived from several donors, those with a higher polarity
produced increased amounts of PEDF and VEGF-A than nonpolarized cells as shown
by analysis of extracellular medium, cellular protein and cellular mRNA. This
indicates that a higher degree of differentiation of RPE cells in vitro
leads to higher production of PEDF and VEGF. The three orders of magnitude
higher levels of expression of PEDF compared to VEGF suggest that PEDF is
critical for neurotrophic support of photoreceptors and maintaining an antiangiogenic outer retinal microenvironment,
while relatively low levels of basolateral VEGF maintain the choriocapillaris
without inducing choroidal neovascularization. The 34 fold increase in PEDF
with polarization further supports the importance of RPE polarization in
maintenance of this neuroprotective function. It is of interest that
neurotrophic PEDF activity was first isolated from conditioned media of
polarized RPE [43] and that subsequent secretion of PEDF from RPE also utilized
polarized cultures [44].
PEDF expression has also been shown to be regulated
during the cell cycle. Pollina et al. reported that amount of PEDF secretion
correlated with cell cycle and secretion was higher in the quiescent stage in
fibroblasts [34]. The PEDF promotor activity in fibroblast-like HDF cells was
found to be age and cell-cycle dependent [45]. In this study, the difference
in the amount of PEDF secretion is also reduced in quiescent vs proliferating
RPE, however, the extent of this effect is not significant compared to the
34-fold difference found between polarized vs nonpolarized cells. This finding
suggests that the increase in PEDF secretion in
the highly differentiated monolayer arose
primarily induction of polarity consistent with our hypothesis. The detailed
mechanism of higher secretory ability of polarized RPE remains to be
elucidated, however, the polarized culture system is a good mimic of the
resting RPE and indication of increased secretion may be related to maturation
of human RPE cell secretory pathways [15,16].
Our studies confirm and extend the
findings from previous studies [15,40], that
VEGF-A is preferentially secreted into the basal side of unstimulated RPE. This
property of polarized secretion may be necessary so that RPE cells can modulate
the homeostasis of the extracellular space around Bruch's membrane and at the
same time modulate the density of endothelial cell fenestrations in the
choroidal blood supply [46,47]. In contrast to VEGF-A, PEDF in this model is
secreted more into the apical side of the RPE and this polarized secretion
pattern is consistent with the in vivo PEDF expression pattern [36,48].
The amount of PEDF secretion in this study is higher than that of found in
monkey eye [36]. It is of interest that in the monkey model, the authors
suggested that polarization of RPE may be an important mechanism that regulates
PEDF secretion [36,49]. Increased PEDF secretion from RPE may be necessary for
retinal neuroprotection. Indeed Mukherjee et al. [50] showed recently that PEDF
produced in the apical media of ARPE-19 cells augmented NPD1-mediated
protection. Another interesting feature of our studies was that, although
interdonor variations exist with respect to the amount of PEDF and VEGF
secretion, the relative apical/basolateral ratio for both PEDF and
VEGF among donors remained remarkably similar.
In further studies to
evaluate the functional ability of this polarized RPE culture system to mimic
human disease, we evaluated the effect of BMP-4 on growth factor secretion
since BMP-4 expression is upregulated in dry AMD [32]. Our experiments showed
that exogenous rhBMP-4 significantly increased basolateral VEGF-A secretion in
a dose-dependent manner. We believe that this is the first demonstration of
polarized VEGF-A secretion by human RPE upon stimulation with BMP-4. Our
results are in agreement with a recent report [27] in which an entirely
different protocol for BMP-4 administration to ARPE-19 cells was employed.
However, our findings differ from another study [51] in which BMP-4 did not
affect VEGF secretion. Clearly, the state of differentiation and polarization of
RPE cells influences the effect of exogenous growth factors (such as BMP-4) on
RPE secretion of VEGF-A. In this context, it can be said that to evaluate RPE
function with various treatments in vitro, polarized RPE might represent
the resting RPE more accurately. Since secretion of VEGF-A was found to be
upregulated by BMP-4, we evaluated the effect of the treatment of human RPE
with noggin, a BMP-4 antagonist [52]. Noggin significantly inhibited VEGF-A
secretion by about 40% under our experimental conditions thereby confirming a
role for BMP-4 in stimulating VEGF-A secretion (p<0.05; data not shown).
Recently, it was shown that in AMD patients with CNV, the RPE in CNV lesions
showed essentially absent immunohistochemical levels of expression of BMP-4
suggesting that lack of BMP-4 may be permissive for pathologic angiogenesis
[53]. It is likely that other factors, such as inflammation regulation RPE
expression levels of BMP-4, and that the very high, pathologic levels of VEGF
found in nonpolarized, transdifferentiated RPE found in CNV lesions are
regulated by factors other than BMP-4 [53].
In conclusion, our
data show that polarity is an important determinant of the level of PEDF and
VEGF secretion in RPE and support the contention that loss of polarity of RPE
in AMD results in marked loss of neurotrophic and vascular support for the
retina potentially leading to photoreceptor loss and blindness.
Materials
and methods
RPE cell culture
. All experiments and procedures were conducted in
compliance with the Declaration of Helsinki. RPE cells were isolated from
human fetal eyes were cultured as previously described [3,54]. Confluent cell
cultures from passages 2 to 4 were used. RPE
were cultured under 3 conditions for comparison: [1]. confluent (1day culture
in 10% fetal bovine serum (FBS) in Dulbecco's
minimum Eagle's medium (DMEM) followed by
1% FBS for three days in 6 well plate); [2] confluent-quiescent (cultured for
additional 7 days in 1% FBS in 6-well plates); and [3] highly differentiated
polarized RPE (grown on Transwell filters for a period of more than 1 month in
1% FBS).
Human RPE monolayer cultures on Transwell filters.
Highly differentiated fetal human RPE cells were
grown utilizing the protocol of Maminishkis et al.[15]with some
modifications [3]. Briefly, primary cultures of human fetal RPE cells from
multiple donors were trypsinized and resuspended in media supplemented with 10%
FBS. Approximately 1.0×105 human RPE cells/cm2 were
seeded on fibronectin-coated Transwell filters (12 mm internal diameter; 0.4 μm
pore size;Corning Costar). RPE cells were cultured on the filtersin 10% FBS containing medium for 1 day and in 1% FBS thereafter for one
month. This resulted in the formation of differentiated polarized monolayers,
with the apical domain corresponding to the retinal facing side of the RPE
monolayer and basolateral domain corresponding to the choroidal facing side of
the RPE monolayer. One milliliter of serum free culture medium was introduced
to both apical and basolateral chambers in experiments to determine secretion.
Measurement of Transepithelial resistance (TER).
TER of RPE
monolayers grown on Transwells was measured with an EVOM epithelial tissue
voltohmmeter (World Precision Instruments) as described [40]. All TER
measurements were made in a cell culture hood within 3 min of removal of
Transwells from the incubator, and the average temperature at the time of
measurement was 32.2 ±1.85ºC. Net TERs were calculated by subtracting the value
of a blank, fibronectin-coated Transwell filter without cells from the
experimental value. Final resistance-area products (Ω·cm2) were
obtained by multiplication with the effective growth area [40].
Confocal
immunofluorescence.
The morphologic features of polarization were
visualized by immunolocalization of ZO-1 and occludin to the junctional
complex, and apical localization of Na/K- ATPase [3,40]. Cultures were also
evaluated for cell cycle status by assessing expression of Ki-67 and p27. RPE
monolayers were fixed in 2% paraformaldehyde followed by blocking with in 5%
BSA before incubating with ZO-1 rabbit polyclonal antibody (1:100 dilution,
Zymed), rabbit polyclonal anti-occludin (1:100, Zymed), monoclonal antibody
labeling Na/K- ATPase (1 μg/ml, Upstate), mouse monoclonal antibody
against Ki-67 (1:100, Millipore) and mouse monoclonal antibody against p27 (1:40, Novocastra Laboratories) at 4°C overnight. The cells
were washed and incubated with FITC conjugated anti-rabbit or anti-mouse
secondary antibody (Jackson Labs) for 30 min. After the immunostaining
procedure, membranes were removed from the inserts with a fine, sharp, sterile
razor blade and mounted on a glass slide with fluorescent mounting medium
containing 4',6-diamidino-2-phenylindole (DAPI; Vector
Laboratories) and viewed on an LSM 510 laser-scanning microscope (Carl Zeiss).
Confluence, polarity and
cell proliferation status.
To differentiate between effects of cell proliferation
and polarity on extent of growth factor secretion, cell cycle status was
evaluated in RPE cultured in three different ways. These consisted of [1]
confluent (1day culture in 10% FBS in DMEM followed by 1% FBS for three days on
glass chamber slide), [2] confluent-quiescent (cultured for additional 7 days
on glass chamber slide), and [3] highly differentiated polarized RPE (grown on
Transwell filters for a > 1 month in 1% FBS). Staining for p27 (highly
expressed in quiescent cells) and Ki-67 (highly expressed in dividing cells)
was performed and relative proportions of p27 and Ki-67 positive cells were
counted from confocal images. In addition, media from the above three culture
conditions was analyzed for VEGF and PEDF secretion.
Scanning Electron
Microscopy.
The monolayer of RPE was fixed in half strength
Karnovsky's fixative and then postfixed in 1% osmium tetroxide. After a
cacodylate buffer rinse, the monolayers were dehydrated through an alcohol
series then transferred from 100% ethanol to 100% hexamethyldisilasane (HMDS).
After two changes in HMDS, the monolayers were allowed to air dry for 24 h. The
membranes with attached monolayers were next mounted on to stubs and coated
with gold and palladium on a sputter-coater. The cells were imaged with a JEOL
JSM 6390 LV Scanning Electron Microscope (filament voltage at 15 KV).
Transmission electron microscopy.
RPE
monolayers were fixed in half strength Karnovsky's fixative for 24 h at 40C.
The cell monolayers were then postfixed in 1% osmium tetroxide for 2h on ice.
The samples were dehydrated in ethyl alcohol and then infiltrated in Eponate
prior to embedding. Ultrathin sections were cut at a thickness of 70nm and
stained with uranyl acetate and lead citrate. Sections were examined on a JEOL
JEM 2100 electron microscope.
BMP-4 treatments.
In both
non-polarized and polarized cells, the RPE culturemedium was
switched to 0% FBS overnight and then replaced with fresh 0% FBS culture medium for 24 h. Recombinant human BMP-4 (0, 10, 25,
50, 75, 100ng/ml, R&D Systems) was introduced to the medium in the
non-polarized cells, and in the medium on both sides (apical and basolateral)
of the membrane for 24 h in the polarized cells. After the incubation period,
the extracellular mediumwas collected for protein secretion
analysis, and the cellswere used for mRNA and protein
quantification studies. In our studies, BMP-4 was introduced to RPE Transwell
filters from both the apical and basolateral compartments each maintained in a
volume of 1ml of the incubation medium. To exclude the possibility of this
modification influencing the secretion properties as compared to the previously
used 0.5ml apical, 1.5ml basolateral medium protocols [15], TER and PEDF
secretion were measured in separate experiments of RPE Transwells maintained in
apical/basolateral volume combinations of 0.5ml/0.5ml, 0.5ml/1.0ml,
0.5ml/1.5ml, 1.0ml/1.0ml incubation media. No significant change in TER or PEDF
secretion among groups could be detected under these experimental conditions
(data not shown) and subsequent experiments were all performed using a
1.0ml/1.0ml incubation medium.
Enzyme-linked immunosorbent assay (ELISA).
In
non-growth factor treated cells, and at the end of experiments in which cells
were treated with BMP-4, the extracellular medium fromcontrol and
treated non-polarized RPE groups and the medium fromthe apical and
basal compartments of the highly polarized RPEgroups were collected
and stored at -80°C until furtheranalysis. Levels of VEGF-A
(Quantikine; R&D Systems) and PEDF (BioProducts) in the medium was measured
accordingto the manufacturers' protocols. In separate experiments,cellular levels of VEGF-A and PEDF were measured asdescribed
previously [40]. Data derived from standard curves wereexpressed as
picograms per milliliter for the two growth factors secretedinto
medium, and as relative difference (x-fold) in growth factorprotein
relative to the untreated control in cellular lysates.
Western blot analysis
for ZO-1 and occludin.
After treatment with BMP-4, the cell lysates weresubjected to Western blot analysis as previously described [54]. Primary
antibodies used were ZO-1 rabbit polyclonal antibody (1:1000 dilution; Zymed)
and anti-occludin rabbit polyclonal antibody (1:500 dilution; Zymed).After
incubation with horseradish peroxidase-conjugatedanti-rabbit
secondary antibody (Vector Laboratories),protein bands were
detected by chemiluminescence (Pierce). To verify equal loading, membranes were
reprobed with GAPDH.
Real-time RT-PCR.
Total
RNA was isolated (TRIzol extraction protocol; Invitrogen), and treated with
DNase (Ambion)to remove contaminating genomic DNA. Reverse transcriptionwas performed with 1 μg total RNA, oligo(dT)15 primer,and
AMV reverse transcriptase according to the manufacturer'sprotocol
(Promega). The PCR experiments were performed on a thermocycler (model LC 480
light cycler; RocheDiagnostics), with SYBR Green (Roche
Diagnostics)as the interaction agent. Each 20 μL PCR mix contained
5 μLcDNA template, 10 μL SYBR Green PCR master mix, and 0.5μM
of each gene-specific primer. Quantification of mRNA was normalized with GAPDH
as thehousekeeping gene. The specificity of the PCR amplificationproducts was checked by performing dissociation melting curveanalysis
and by 1% agarose gel electrophoresis. Reaction conditionswere as
follows: 5 min at 95°C followed by 45 cyclesof 10 sec at 95°C, 20
sec at 55°C, and 20 secat 72°C. The sequences of primers used for
human VEGF-Awere forward: 5'-TCT TCA AGC CAT CCT CTG TG-3',
reverse: 5'-ATC CGC ATA ATC TGC ATG GT-3'; PEDF forward: 5'-ACG CTA TGG CTT GGA
TTC AG-3', reverse: 5'-GGT CAA ATT CTG GGT CAC TTT C-3'. Relativemultiples
of changes in mRNA expression were determined by calculationof -2∆∆CT.
Results are reported as the mean difference inrelative multiples of
change in mRNA expression ± SEM.
TUNEL Staining.
Apoptosis
was detected by the terminal deoxynucleotidyltransferase
(TdT)-mediated dUTP-biotin nick end-labeling (TUNEL)method
according to the manufacturer's protocol (ApopTagperoxidase in situ
apoptosis detection kit; Chemicon). Briefly, cells were fixed in 3%
paraformaldehyde solutionand rinsed with PBS. After treatment with
3% H2O2 at room temperaturefor 5 min, the
cells were incubated with TdT enzyme for1 h at 37°C in a humidified
chamber. The digoxigenin (DIG) labelednucleotides incorporated
into DNA breaks were detected by applyinganti-digoxigenin conjugate
and peroxidase substrate.
Statistical
analysis.
All
values were expressed as mean± S.E.M. Differences between two groups were
analyzed by paired t-test, and those among multiple groups were analyzed by
analysis of variance (ANOVA) followed by Sheffe's test. Differences with a P
value of less than 0.05 were considered to be significant.
Acknowledgments
The authors thank Ernesto Barron for
extensive technical assistance with confocal and electron microscopy and for
preparation of figures. Supported by The
Arnold and Mabel Beckman Foundation, NationalInstitutes of Health
Grants (EY01545, EY03040), and a grant to the Department of Ophthalmology by
Research toPrevent Blindness, Inc.
Conflicts of Interest
The authors have no conflict of interests to declare.
References
-
1.
Hogan MJ. Role of the retinal pigment epithelium in macular disease.
Trans Am Acad Ophthalmol Otolaryngol.
1972;
76:
64
-80.
[PubMed]
.
-
2.
Sheedlo
HJ
, Li
L
and Turner
JE.
Effects of RPE-cell factors secreted from permselective fibers on retinal cells in vitro.
Brain Res.
1992;
587:
327
-337.
[PubMed]
.
-
3.
Sonoda
S
, Spee
C
, Barron
E
, Ryan
SJ
, Kannan
R
and Hinton
DR.
A protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells.
Nature Protocols.
2009;
4:
662
-673.
.
-
4.
Hu
J
and Bok
D.
A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers.
Mol Vis.
2001;
7:
14
-19.
[PubMed]
.
-
5.
Holtkamp
GM
, Van
Rossem M
, de Vos
AF
, Willekens
B
, Peek
R
and Kijlstra
A.
Polarized secretion of IL-6 and IL-8 by human retinal pigment epithelial cells.
Clin Exp Immunol.
1998;
112:
34
-43.
[PubMed]
.
-
6.
Blaauwgeers
HG
, Holtkamp
GM
and Rutten
H.
Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation.
Am J Pathol.
1999;
155:
421
-428.
[PubMed]
.
-
7.
Ban
Y
and Rizzolo
LJ.
A culture model of development reveals multiple properties of RPE tight junctions.
Mol Vis.
1997;
3:
18
[PubMed]
.
-
8.
Dunn
KC
, Aotaki-Keen
AE
, Putkey
FR
and Hjelmeland
LM.
ARPE-19, a human retinal pigment epithelial cell line with differentiated properties.
Exp Eye Res.
1996;
62:
155
-169.
[PubMed]
.
-
9.
Marin-Castano
ME
, Csaky
KG
and Cousins
SW.
Nonlethal oxidant injury to human retinal pigment epithelium cells causes cell membrane blebbing but decreased MMP-2 activity.
Invest Ophthalmol Vis Sci.
2005;
46:
3331
-3340.
[PubMed]
.
-
10.
Handa
JT
, Reiser
KM
, Matsunaga
H
and Hjelmeland
LM.
The advanced glycation endproduct pentosidine induces the expression of PDGF-B in human retinal pigment epithelial cells.
Exp Eye Res.
1998;
66:
411
-419.
[PubMed]
.
-
11.
Luo
Y
, Zhuo
Y
, Fukuhara
M
and Rizzolo
LJ.
Effects of culture conditions on heterogeneity and the apical junctional complex of the ARPE-19 cell line.
Invest Ophthalmol Vis Sci.
2006;
47:
3644
-3655.
[PubMed]
.
-
12.
Rahner
C
, Fukuhara
M
, Peng
S
, Kojima
S
and Rizzolo
LJ.
The apical and basal environments of the retinal pigment epithelium regulate the maturation of tight junctions during development.
J Cell Sci.
2004;
117:
3307
-3318.
[PubMed]
.
-
13.
Peng
S
, Rahner
C
and Rizzolo
LJ.
Apical and basal regulation of the permeability of the retinal pigment epithelium.
Invest Ophthalmol Vis Sci.
2003;
44:
808
-817.
[PubMed]
.
-
14.
Geisen
P
, McColm
JR
, King
BM
and Hartnett
ME.
Characterization of barrier properties and inducible VEGF expression of several types of retinal pigment epithelium in medium-term culture.
Curr Eye Res.
2006;
31:
739
-748.
[PubMed]
.
-
15.
Maminishkis
A
, Chen
S
and Jalickee
S.
Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue.
Invest Ophthalmol Vis Sci.
2006;
47:
3612
-3624.
[PubMed]
.
-
16.
Shi
G
, Maminishkis
A
and Banzon
T.
Control of Chemokine Gradients by the Retinal Pigment Epithelium.
Invest Ophthalmol Vis Sci.
2008;
49:
4620
-4630.
[PubMed]
.
-
17.
Ohno-Matsui
K
, Morita
I
and Tombran-Tink
J.
Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF.
J Cell Physiol.
2001;
189:
323
-333.
[PubMed]
.
-
18.
Sakamoto
T
, Sakamoto
H
, Hinton
DR
, Spee
C
, Ishibashi
T
and Ryan
SJ.
In vitro studies of human choroidal endothelial cells.
Curr Eye Res.
1995;
14:
621
-627.
[PubMed]
.
-
19.
Miller
H
, Miller
B
and Ryan
SJ.
The role of retinal pigment epithelium in the involution of subretinal neovascularization.
Invest Ophthalmol Vis Sci.
1986;
27:
1644
-1652.
[PubMed]
.
-
20.
Shweiki
D
, Itin
A
, Soffer
D
and Keshet
E.
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
Nature.
1992;
359:
843
-845.
[PubMed]
.
-
21.
Adamis
AP
, Miller
JW
and Bernal
MT.
Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.
Am J Ophthalmol.
1994;
118:
445
-450.
[PubMed]
.
-
22.
Dawson
DW
, Volpert
OV
and Gillis
P.
Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.
Science.
1999;
285:
245
-248.
[PubMed]
.
-
23.
McLeod
DS
, Grebe
R
, Bhutto
I
, Merges
C
, Baba
T
and Lutty
GA.
Relationship between RPE and choriocapillaris in age-related macular degeneration.
Invest Ophthalmol Vis Sci.
2009;
50:
4982
-4991.
[PubMed]
.
-
24.
Vogt
SD
, Curcio
CA
, Wang
L
, Li
CM
, McGwin
G
, Medeiros
NE Jr
, Philp
NJ
, Kimble
JA
and Read
RW.
Altered retinal pigment epithelium morphology is associated with decreased expression of complement regulatory protein CD46 and ion transporter MCT3 in geographic atrophy of age-related maculopathy.
Invest Ophthalmol Vis Sci.
2009;
50:
E
-Abstract 4180.
.
-
25.
Bian
ZM
, Elner
SG
and Elner
VM.
Regulation of VEGF mRNA expression and protein secretion by TGF-beta2 in human retinal pigment epithelial cells.
Exp Eye Res.
2007;
84:
812
-822.
[PubMed]
.
-
26.
Zamiri
P
, Masli
S
, Streilein
JW
and Taylor
AW.
Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation.
Invest Ophthalmol Vis Sci.
2006;
47:
3912
-3918.
[PubMed]
.
-
27.
Vogt
RR
, Unda
R
, Yeh
LC
, Vidro
EK
, Lee
JC
and Tsin
AT.
Bone morphogenetic protein-4 enhances vascular endothelial growth factor secretion by human retinal pigment epithelial cells.
J Cell Biochem.
2006;
98:
1196
-1202.
[PubMed]
.
-
28.
Muller
F
, Rohrer
H
and Vogel-Hopker
A.
Bone morphogenetic proteins specify the retinal pigment epithelium in the chick embryo.
Development.
2007;
134:
3483
-3493.
[PubMed]
.
-
29.
Furuta
Y
, Piston
DW
and Hogan
BL.
Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development.
Development.
1997;
124:
2203
-2212.
[PubMed]
.
-
30.
Mathura
JR Jr
, Jafari
N
and Chang
JT.
Bone morphogenetic proteins-2 and -4: negative growth regulators in adult retinal pigmented epithelium.
Invest Ophthalmol Vis Sci.
2000;
41:
592
-600.
[PubMed]
.
-
31.
Wordinger
RJ
and Clark
AF.
Bone morphogenetic proteins and their receptors in the eye.
Exp Biol Med (Maywood).
2007;
232:
979
-992.
[PubMed]
.
-
32.
Zhu
D
, Wu
J
, Spee
C
, Ryan
SJ
and Hinton
DR.
BMP4 mediates oxidative stress-induced retinal pigment epithelial cell senescence and is over expressed in age-related macular degeneration.
J Biol Chem.
2009;
284:
9529
-9539.
[PubMed]
.
-
33.
Pignolo
RJ
, Francis
MK
, Rotenberg
MO
and Cristofalo
VJ.
Putative role for EPC-1/PEDF in the G0 growth arrest of human diploid fibroblasts.
J Cell Physiol.
2003;
195:
12
-20.
[PubMed]
.
-
34.
Pollina
EA
, Legesse-Miller
A
, Haley
EM
, Goodpaster
T
, Randolph-Habecker
J
and Coller
HA.
Regulating the angiogenic balance in tissues.
Cell Cycle.
2008;
7:
2056
-2070.
[PubMed]
.
-
35.
Rothhammer
T
, Bataille
F
, Spruss
T
, Eissner
G
and Bosserhoff
AK.
Functional implication of BMP4 expression on angiogenesis in malignant melanoma.
Oncogene.
2007;
26:
4158
-4170.
[PubMed]
.
-
36.
Becerra
SP
, Fariss
RN
, Wu
YQ
, Montuenga
LM
, Wong
P
and Pfeffer
BA.
Pigment epithelium-derived factor in the monkey retinal pigment epithelium and interphotoreceptor matrix: apical secretion and distribution.
Exp Eye Res.
2004;
78:
223
-234.
[PubMed]
.
-
37.
Gao G, Li Y, Zhang D, Gee S, Crosson C, Ma J. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization.
FEBS Lett.
2001;
489:
270
-276.
[PubMed]
.
-
38.
Lopez PF, Sippy BD, Lambert HM, Thach AB, Hinton DR. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes.
Invest Ophthalmol Vis Sci.
1996;
37:
855
-868.
[PubMed]
.
-
39.
Ablonczy
Z
, Prakasam
A
, Fant
J
, Fauq
A
, Crosson
C
and Sambamurti
K.
Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through gamma-secretase.
J Biol Chem.
2009;
284:
30177
-30186.
[PubMed]
.
-
40.
Kannan
R
, Zhang
N
and Sreekumar
PG.
Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells.
Mol Vis.
2006;
12:
1649
-1659.
[PubMed]
.
-
41.
Quinn
RH
and Miller
SS.
Ion transport mechanisms in native human retinal pigment epithelium.
Invest Ophthalmol Vis Sci.
1992;
33:
3513
-3527.
[PubMed]
.
-
42.
Quinn
RH
, Quong
JN
and Miller
SS.
Adrenergic receptor activated ion transport in human fetal retinal pigment epithelium.
Invest Ophthalmol Vis Sci.
2001;
42:
255
-264.
[PubMed]
.
-
43.
Tombran-Tink
J
and Johnson
LV.
Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells.
Invest Ophthalmol Vis Sci.
1989;
30:
1700
-1707.
[PubMed]
.
-
44.
Tombran-Tink
J
, Shivaram
SM
, Chader
GJ
, Johnson
LV
and Bok
D.
Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity.
J Neurosci.
1995;
15:
4992
-5003.
[PubMed]
.
-
45.
Kojima
T
, Nakahama
K
, Yamamoto
K
, Uematsu
H
and Morita
I.
Age- and cell cycle-dependent changes in EPC-1/PEDF promoter activity in human diploid fibroblast-like (HDF) cells.
Mol Cell Biochem.
2006;
293:
63
-69.
[PubMed]
.
-
46.
Roberts
WG
and Palade
GE.
Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor.
J Cell Sci.
1995;
108(Pt 6):
2369
-2379.
[PubMed]
.
-
47.
Yokomori
H
, Oda
M
and Yoshimura
K.
Vascular endothelial growth factor increases fenestral permeability in hepatic sinusoidal endothelial cells.
Liver Int.
2003;
23:
467
-475.
[PubMed]
.
-
48.
Karakousis
PC
, John
SK
and Behling
KC.
Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues.
Mol Vis.
2001;
7:
154
-163.
[PubMed]
.
-
49.
Pfeffer
BA
, Becerra
SP
, Borst
DE
and Wong
P.
Expression of transthyretin and retinol binding protein mRNAs and secretion of transthyretin by cultured monkey retinal pigment epithelium.
Mol Vis.
2004;
10:
23
-30.
[PubMed]
.
-
50.
Mukherjee
PK
, Marcheselli
VL
, Barreiro
S
, Hu
J
, Bok
D
and Bazan
NG.
Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling.
Proc Natl Acad Sci U S A.
2007;
104:
13152
-13157.
[PubMed]
.
-
51.
Nagineni
CN
, Samuel
W
and Nagineni
S.
Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases.
J Cell Physiol.
2003;
197:
453
-462.
[PubMed]
.
-
52.
Balemans
W
and Van
Hul W.
Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators.
Dev Biol.
2002;
250:
231
-250.
[PubMed]
.
-
53.
Zhu
DH
, Deng
X
, Xu
J
and Hinton
DR.
What determines the switch between atrophic and neovascular forms of age related macular degeneration? - the role of BMP4 induced senescence.
Aging.
2009;
1:
740
-745.
[PubMed]
.
-
54.
Sreekumar
PG
, Kannan
R
, Yaung
J
, Spee
CK
, Ryan
SJ
and Hinton
DR.
Protection from oxidative stress by methionine sulfoxide reductases in RPE cells.
Biochem Biophys Res Commun.
2005;
334:
245
-253.
[PubMed]
.